Skip to main navigation Skip to search Skip to main content

Tumor markers

Research line: Impact

Description of impact

Aberrant Glycosylation of Serum Proteins as possible Tumour Markers. At the present time, studies are focused on pancreatic and prostate carcinomas and in particular, in the aberrant glycosylation of human pancreatic ribonuclease, acute-phase proteins and PSA (prostate specific antigen). To be extended to other glycoproteins (By Proteomics and Glycomics approaches)